BALDWIN INSURANCE GROUP INC/ (BWIN) Stock Fundamental Analysis
USA - NASDAQ:BWIN - US05589G1022 - Common Stock
31.31 USD
+1.23 (+4.09%)
31.31 USD
0 (0%)
BWIN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 146 industry peers in the Insurance industry. Both the profitability and financial health of BWIN have multiple concerns. BWIN is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year BWIN was profitable.
In the past year BWIN has reported a negative cash flow from operations.
In the past 5 years BWIN always reported negative net income.
In multiple years BWIN reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of BWIN (-0.48%) is worse than 84.93% of its industry peers.
With a Return On Equity value of -2.82%, BWIN is not doing good in the industry: 84.93% of the companies in the same industry are doing better.
BWIN has a Return On Invested Capital of 2.72%. This is comparable to the rest of the industry: BWIN outperforms 56.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.48% | ||
| ROE | -2.82% | ||
| ROIC | 2.72% |
ROA(3y)-1.49%
ROA(5y)N/A
ROE(3y)-9.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Operating Margin value of 6.43%, BWIN is not doing good in the industry: 69.18% of the companies in the same industry are doing better.
The Gross Margin of BWIN (27.55%) is better than 88.36% of its industry peers.
In the last couple of years the Gross Margin of BWIN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.43% | ||
| PM (TTM) | N/A | ||
| GM | 27.55% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.47%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWIN is destroying value.
Compared to 1 year ago, BWIN has more shares outstanding
BWIN has a worse debt/assets ratio than last year.
2.2 Solvency
BWIN has an Altman-Z score of 1.16. This is a bad value and indicates that BWIN is not financially healthy and even has some risk of bankruptcy.
BWIN's Altman-Z score of 1.16 is fine compared to the rest of the industry. BWIN outperforms 79.45% of its industry peers.
A Debt/Equity ratio of 2.55 is on the high side and indicates that BWIN has dependencies on debt financing.
BWIN has a Debt to Equity ratio of 2.55. This is amonst the worse of the industry: BWIN underperforms 94.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.55 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.16 |
ROIC/WACC0.34
WACC8.09%
2.3 Liquidity
A Current Ratio of 1.23 indicates that BWIN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.23, BWIN belongs to the top of the industry, outperforming 81.51% of the companies in the same industry.
BWIN has a Quick Ratio of 1.23. This is a normal value and indicates that BWIN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BWIN (1.23) is better than 81.51% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 1.23 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 25.56% over the past year.
The Earnings Per Share has been growing by 23.83% on average over the past years. This is a very strong growth
The Revenue has grown by 11.43% in the past year. This is quite good.
Measured over the past years, BWIN shows a very strong growth in Revenue. The Revenue has been growing by 34.78% on average per year.
EPS 1Y (TTM)25.56%
EPS 3Y23.83%
EPS 5YN/A
EPS Q2Q%23.53%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y34.78%
Revenue growth 5YN/A
Sales Q2Q%11.47%
3.2 Future
Based on estimates for the next years, BWIN will show a very strong growth in Earnings Per Share. The EPS will grow by 21.28% on average per year.
BWIN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.05% yearly.
EPS Next Y12.96%
EPS Next 2Y19.34%
EPS Next 3Y21.28%
EPS Next 5YN/A
Revenue Next Year9.43%
Revenue Next 2Y11.46%
Revenue Next 3Y12.54%
Revenue Next 5Y14.05%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
BWIN is valuated rather expensively with a Price/Earnings ratio of 18.75.
Based on the Price/Earnings ratio, BWIN is valued a bit more expensive than the industry average as 63.70% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 27.20. BWIN is valued slightly cheaper when compared to this.
BWIN is valuated correctly with a Price/Forward Earnings ratio of 14.66.
BWIN's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.71. BWIN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.75 | ||
| Fwd PE | 14.66 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BWIN is valued a bit more expensive than the industry average as 68.49% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 24.73 |
4.3 Compensation for Growth
BWIN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BWIN's earnings are expected to grow with 21.28% in the coming years.
PEG (NY)1.45
PEG (5Y)N/A
EPS Next 2Y19.34%
EPS Next 3Y21.28%
5. Dividend
5.1 Amount
No dividends for BWIN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
31.31
+1.23 (+4.09%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners103.81%
Inst Owner ChangeN/A
Ins Owners0.94%
Ins Owner Change-2.58%
Market Cap3.72B
Analysts77.5
Price Target42.26 (34.97%)
Short Float %7.94%
Short Ratio6.7
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.21%
Min EPS beat(2)-1.3%
Max EPS beat(2)-1.11%
EPS beat(4)1
Avg EPS beat(4)-0.91%
Min EPS beat(4)-5.25%
Max EPS beat(4)4.03%
EPS beat(8)5
Avg EPS beat(8)3.4%
EPS beat(12)7
Avg EPS beat(12)2.34%
EPS beat(16)9
Avg EPS beat(16)2.49%
Revenue beat(2)0
Avg Revenue beat(2)-1.99%
Min Revenue beat(2)-3.04%
Max Revenue beat(2)-0.93%
Revenue beat(4)0
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-4.36%
Max Revenue beat(4)-0.93%
Revenue beat(8)0
Avg Revenue beat(8)-1.61%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.43%
PT rev (3m)-11.31%
EPS NQ rev (1m)-3.48%
EPS NQ rev (3m)-22.67%
EPS NY rev (1m)-6.81%
EPS NY rev (3m)-7.57%
Revenue NQ rev (1m)-0.22%
Revenue NQ rev (3m)-3.12%
Revenue NY rev (1m)-1.72%
Revenue NY rev (3m)-1.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.75 | ||
| Fwd PE | 14.66 | ||
| P/S | 2.54 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.89 | ||
| P/tB | N/A | ||
| EV/EBITDA | 24.73 |
EPS(TTM)1.67
EY5.33%
EPS(NY)2.14
Fwd EY6.82%
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS12.31
BVpS5.32
TBVpS-14.45
PEG (NY)1.45
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.48% | ||
| ROE | -2.82% | ||
| ROCE | 3.44% | ||
| ROIC | 2.72% | ||
| ROICexc | 2.82% | ||
| ROICexgc | 26.52% | ||
| OM | 6.43% | ||
| PM (TTM) | N/A | ||
| GM | 27.55% | ||
| FCFM | N/A |
ROA(3y)-1.49%
ROA(5y)N/A
ROE(3y)-9.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.47%
GM growth 5YN/A
F-Score4
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.55 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.82 | ||
| Cap/Depr | 38.89% | ||
| Cap/Sales | 2.97% | ||
| Interest Coverage | 0.84 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 1.23 | ||
| Altman-Z | 1.16 |
F-Score4
WACC8.09%
ROIC/WACC0.34
Cap/Depr(3y)30.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.56%
EPS 3Y23.83%
EPS 5YN/A
EPS Q2Q%23.53%
EPS Next Y12.96%
EPS Next 2Y19.34%
EPS Next 3Y21.28%
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y34.78%
Revenue growth 5YN/A
Sales Q2Q%11.47%
Revenue Next Year9.43%
Revenue Next 2Y11.46%
Revenue Next 3Y12.54%
Revenue Next 5Y14.05%
EBIT growth 1Y345.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year146.39%
EBIT Next 3Y51.97%
EBIT Next 5Y36.26%
FCF growth 1Y187.63%
FCF growth 3Y24.41%
FCF growth 5YN/A
OCF growth 1Y128.81%
OCF growth 3Y36.54%
OCF growth 5YN/A